Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ossama Al-Mefty

Showing results (191-200 of 195) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 195 results.
Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.
Neuro-Oncology|May 20, 2021
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial resultsWenya Linda Bi, Lakshmi Nayak, David M Meredith, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Neuro-Oncology|February 8, 2017
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomasGanesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, et al.
Neuro-Oncology|March 11, 2015
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastomaShakti H Ramkissoon, Wenya Linda Bi, Steven E Schumacher, et al.
Pageof 20

Showing results (191-200 of 195) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 195 results.
Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.
Neuro-Oncology|May 20, 2021
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial resultsWenya Linda Bi, Lakshmi Nayak, David M Meredith, et al.
Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.
Neuro-Oncology|February 8, 2017
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomasGanesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, et al.
Neuro-Oncology|March 11, 2015
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastomaShakti H Ramkissoon, Wenya Linda Bi, Steven E Schumacher, et al.
Pageof 20